Trans-splicing molecules
US-2026078380-A1 · Mar 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Sun Junwei patents
Sun Junwei is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Sun Junwei |
| Total patents | 35 |
| First publication | Dec 27, 2018 |
| Latest publication | Mar 19, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Neuroprotective gene therapy targeting the AKT pathway
US-12533423-B2 · Jan 27, 2026 · US
Trans-splicing molecules
US-12442003-B2 · Oct 14, 2025 · US
Methods and compositions for treatment of disorders and diseases involving RDH12
US-12419973-B2 · Sep 23, 2025 · US
Gene therapy for ocular disorders
US-12403204-B2 · Sep 2, 2025 · US
Trans-splicing molecules
US-2024318186-A1 · Sep 26, 2024 · US
Methods and compositions for treatment of ocular disorders and blinding diseases
US-12097267-B2 · Sep 24, 2024 · US
Gene therapy for ocular disorders
US-2024218394-A1 · Jul 4, 2024 · US
Trans-splicing molecules
US-11993776-B2 · May 28, 2024 · US
AAV vector compositions and methods for gene transfer to cells, organs and tissues
US-11939590-B1 · Mar 26, 2024 · US
Recent patents
Latest publications not already listed above.
Gene therapy for ocular disorders
US-11879133-B2 · Jan 23, 2024 · US
Gene therapy for ocular disorders
US-11827898-B2 · Nov 28, 2023 · US
Gene therapy for treating peroxisomal disorders
US-11793887-B2 · Oct 24, 2023 · US
Gene therapy for ocular disorders
US-2023233709-A1 · Jul 27, 2023 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2023132391-A9 · Apr 27, 2023 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2023037283-A9 · Feb 2, 2023 · US
Gene therapy for ocular disorders
US-11564996-B2 · Jan 31, 2023 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2023009257-A1 · Jan 12, 2023 · US
Neuroprotective gene therapy targeting the akt pathway
US-2022143217-A1 · May 12, 2022 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2022118111-A1 · Apr 21, 2022 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2022118110-A1 · Apr 21, 2022 · US
Methods and compositions for treatment of disorders and diseases involving RDH12
US-11197936-B2 · Dec 14, 2021 · US
Gene therapy for ocular disorders
US-2021330816-A1 · Oct 28, 2021 · US
Gene therapy for ocular disorders
US-11090392-B2 · Aug 17, 2021 · US
Trans-splicing molecules
US-2021155938-A1 · May 27, 2021 · US
Methods and compositions for treatment of ocular disorders and blinding diseases
US-2021060176-A1 · Mar 4, 2021 · US
Methods and compositions for treatment of ocular disorders and blinding diseases
US-10857240-B2 · Dec 8, 2020 · US
Gene therapy for ocular disorders
US-2020172929-A1 · Jun 4, 2020 · US
Synergistic combination of neuronal viability factors and uses thereof
US-10668129-B2 · Jun 2, 2020 · US
Gene therapy for ocular disorders
US-2020131532-A1 · Apr 30, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Pennsylvania | 34 |
| Ascidian Therapeutics Inc | 5 |
| Univ Southern California | 2 |
| The Research Institute Of The Mcgill Univ Health Centre | 2 |
| Inst Nat Sante Rech Med | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N15/86 | 35 |
| C12N2750/14143 | 35 |
| A61P27/02 | 30 |
| A61K48/005 | 29 |
| C12N2800/22 | 24 |